Antiplatelet Use in Dementia Subtypes

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

683 participants

Study Classification

OBSERVATIONAL

Study Start Date

2016-12-31

Study Completion Date

2025-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This population-based retrospective cohort study aimed to evaluate the appropriateness of antiplatelet therapy use among older adults with all-cause dementia and across different dementia subtypes. Medical records of patients aged 65 years and older who were evaluated at a tertiary-level geriatric outpatient clinic were reviewed. Dementia subtypes were classified according to internationally accepted diagnostic criteria. Patterns of antiplatelet use were assessed in accordance with current guideline recommendations. The study sought to determine the appropriateness of antiplatelet use across dementia subtypes and to describe real-world prescribing practices in this population.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Dementia Dementia Disorder

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Antiplatelet therapy Older adults Dementia subtypes

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Dementia cohort

This cohort includes older adults aged 65 years and older diagnosed with dementia who were evaluated in a tertiary geriatric outpatient clinic. No intervention was assigned, as this is a retrospective observational study.

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age 65 years and older.
* Diagnosis of dementia based on internationally accepted diagnostic criteria.
* Evaluation at a tertiary-level geriatric outpatient clinic.

Exclusion Criteria

* Patients with incomplete or inaccessible medical records.
* Individuals with missing data on antiplatelet therapy use.

Minimum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

ZEHRA SARIKAYA DEMIRBAS

MD, Geriatrics Fellow

Responsibility Role PRINCIPAL_INVESTIGATOR

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

GTRH-ANTIPL-DEM-01

Identifier Type: -

Identifier Source: org_study_id